$IMDZ IMMUNE DESIGN CORP. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IMMUNE DESIGN CORP..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in IMMUNE DESIGN CORP.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
IMMUNE DESIGN CORP. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Alta Partners VIII, L.P. | 10% Owner | 2,482,775 | 13,158,708 | Jul 31 2014 | |||
| ATWOOD BRIAN G | Director | 0 | 0 | Jan 06 2016 | |||
| ATWOOD BRIAN G | Director | 2,208,210 | 11,703,513 | Jan 09 2015 | |||
| BALTIMORE DAVID | Director | 0 | 0 | Apr 04 2019 | |||
| BALTIMORE DAVID | Director | 0 | 0 | Jan 09 2015 | |||
| BERGER FRANKLIN M | Director | 0 | 0 | Apr 04 2019 | |||
| BERGER FRANKLIN M | Director | 50,000 | 265,000 | Jan 09 2015 | |||
| Brady Stephen R | EVP, Strategy & Finance | 0 | 0 | Apr 04 2019 | |||
| Brady Stephen R | Chief Business Officer | 0 | 0 | Jan 09 2015 | |||
| BVF PARTNERS L P/IL | 10% Owner | 2,502,758 | 13,264,617 | Dec 04 2018 | |||
| COLEMAN LEWIS W | Director | 0 | 0 | Apr 04 2019 | |||
| COLUMN GROUP L P | 10% Owner | 0 | 0 | Apr 02 2019 | |||
| Gombotz Wayne | Chief Development Officer | 0 | 0 | Apr 04 2019 | |||
| GUTHART LEO | 10% Owner | 3,102,969 | 16,445,736 | May 22 2017 | |||
| Kelley Susan L. | Director | 0 | 0 | Apr 04 2019 | |||
| Kenney Richard T | Chief Medical Officer | 7,522 | 39,867 | Jan 06 2016 | |||
| Kenney Richard T | Chief Medical Officer | 0 | 0 | Jan 09 2015 | |||
| Paya Carlos V | President and CEO | 0 | 0 | Apr 04 2019 | |||
| PENHOET EDWARD | Director | 0 | 0 | Apr 04 2019 | |||
| PENHOET EDWARD | Director | 2,482,775 | 13,158,708 | Jan 09 2015 | |||
| ProQuest Investments IV, L.P. | 10% Owner | 1,983,858 | 10,514,447 | May 13 2015 | |||
| ProQuest Investments IV, L.P. | 10% Owner | 2,695,757 | 14,287,512 | Jul 31 2014 | |||
| Rickey James Paul | VP, Finance and Administration | 0 | 0 | Jan 09 2015 | |||
| RINGO WILLIAM R | Director | 0 | 0 | Apr 04 2019 | |||
| RINGO WILLIAM R | Director | 0 | 0 | Jan 09 2015 | |||
| Svennilson Peter | Director | 2,681,000 | 14,209,300 | Jan 08 2018 | |||
| ter Meulen Jan Henrik | Chief Scientific Officer | 0 | 0 | Apr 04 2019 | |||
| ter Meulen Jan Henrik | Chief Scientific Officer | 0 | 0 | Jan 09 2015 | |||
| Versant Venture Capital III, L.P. | 10% Owner | 2,208,210 | 11,703,513 | Jul 31 2014 | |||
| Yurasov Sergey | Sr. VP, Clinic. Devel. & CMO | 0 | 0 | Apr 04 2019 |